Sibusiso B. Maseko

A proteome-scale map of the SARS-CoV-2–human contactome

Dae‐Kyum Kim, Benjamin Weller, Chung‐Wen Lin et al. · Nature Biotechnology · 2022 · 63 citations · Full text

Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations

Victor T. Sabe, Gideon F. Tolufashe, Collins U. Ibeji et al. · Journal of Molecular Modeling · 2019 · 35 citations · Full text

Pulmonary Tuberculosis, Drug Target, Biochemistry +12

The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape

Charlotte Vandermeulen, Tina O’Grady, Jérôme Wayet et al. · PLoS Pathogens · 2021 · 31 citations · Full text

Viral Replication, Genetics, Rna Splicing +18

Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies

Sibusiso B. Maseko, Satheesh Natarajan, Vikas Sharma et al. · Protein Expression and Purification · 2016 · 25 citations · Full text

Protease Mutants, Viral Replication, Inclusion Bodies +11

AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor

Philipp Trepte, Christopher Secker, Julien Olivet et al. · Molecular Systems Biology · 2024 · 20 citations · Full text

Sars-cov-2 Inhibitor, Drug Target, Engineering +8